Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints a prospective observational study

Gynecological Endocrinology

Volumn 27, Issue 10, 2011, Pages 844-848

  Rostock, Matthias ^a,b   Fischer, Julia ^b   Mumm, Andreas ^b   Stammwitz, Ute ^c   Saller, Reinhard ^a   Bartsch, Hans Helge ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Schaper and Brmmer   (Germany)

Author keywords

Black cohosh; breast cancer; Cimicifuga racemosa; climacteric complaints; hot flushes; Menopause Rating Scale II; tamoxifen

Indexed keywords

2 PROPANOL; CIMICIFUGA RACEMOSA EXTRACT; TAMOXIFEN;

ADULT; AGED; ANXIETY; ARTHRALGIA; ARTICLE; BONE PAIN; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CIMICIFUGA RACEMOSA; CLINICAL ARTICLE; DROWSINESS; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENDOMETRIUM POLYP; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE RATING SCALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; RATING SCALE; SLEEP DISORDER; SWEATING; UROGENITAL TRACT DISEASE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANXIETY; BREAST NEOPLASMS; CIMICIFUGA; ESTROGEN ANTAGONISTS; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PATIENT DROPOUTS; PHYTOTHERAPY; PLANT EXTRACTS; RHIZOME; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SLEEP DISORDERS; SWEATING; TAMOXIFEN;

EID: 80051701849     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.538097     Document Type: Article

References (30)

1. Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomized comparison: trial stopped. Lancet 2004;363:453-455
2. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomizedtrial.Ann InternMed 2006;145:869-879
3. Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 2009;25:166-174
4. Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-122
5. Julia Molla MD, Garcia-Sanchez Y, Romeu Sarri A, Perezlopez FR. Cimicifuga racemosa treatment and health related quality of life in post-menopausal Spanish women. Gynecol Endocrinol 2009;25:21-26
6. Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu Jiao C, Liske E. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007;58:31-41
7. Oktem M, Eroglu D, Karahan HB, Taskintuna N, Kuscu E, Zeyneloglu HB. Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial. Adv Ther 2007;24:448-461
8. Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005;20:30-35
9. Palacio C, Masri G, Mooradian AD. Black cohosh for the management of menopausal symptoms : a systematic review of clinical trials. Drugs Aging 2009;26:23-36
10. Sammartino A, Tommaselli GA, Gargano V, di Carlo C, Attianese W, Nappi C. Short-term effects of a combination of isoflavones, lignans and Cimicifuga racemosa on climacteric-related symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled trial. G ynecol Endocrinol 2006;22:646-650
11. Reame NE, Lukacs JL, Padmanabhan V, Eyvazzadeh AD, Smith YR, Zubieta JK. Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause 2008;15:832-840
12. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. In vitro effects of the Cimicifuga racemosa extract BNO 1055 Maturitas 2003;44 (Suppl 1):S31-S38
13. Walji R, Boon H, Guns E, Oneschuk D, Younus J. Black cohosh (Cimicifuga racemosa L. Nutt.): safety and efficacy for cancer patients. Support Care Cancer 2007;15:913-921
14. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008;199:455-466
15. Bodinet C, Freudenstein J. Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res Treat 2002;76:1-10
16. Freudenstein J, Dasenbrock C, Nisslein T. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Cancer Res 2002;62:3448-3452
17. Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, Lo KM, Moore A, Rosenman PJ, Kaufman EL, Neugut AI, Grann VR. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-2745
18. Hernandez Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44 (Suppl 1): S59-S65
19. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1 J Clin Oncol 2006;24:2836-2841
20. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 2004;22:515-521
21. Sickmueller B, Mueller J. Observational studies - the German experience. Regul Aff J 2004;12:247-250
22. Potthoff P, Heinemann L, Schneider HP. Menopause-Rating- Skala (MRS II): methodische standardisierung in der deutschen bevö lkerung. Zentralbl Gynakol 2000;122: 280-286
23. Schneider HPG, Behr HM. Contemporary evaluation of climacteric complaints: its impact on quality of life. In: Heinemann LAJ, Potthoff P, Schneider HPG, editors. Hormone replacement therapy and quality of life. New York: The Parthenon Publishing Group, 2003:45-61
24. Hauser GA, Ernst U. Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I). Zentralbl Gynakol 1999;121:530-536
25. Briese V, Stammwitz U, Friede M. Wechseljahrestherapie ohne Hormone - Ergebnisse einer aktuellen Anwendungsbeobachtung. J Menopause 2005;12:11-12
26. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005;105:1074-1083
27. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Womens Health Gend Based Med 2002;11:163-174
28. Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003;21:602-606
29. Grunfeld EA, Hunter MS, Sikka P, Mittal S. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 2005;59:97-102
30. Ziller V, Kalder M, Albert US, Holzhauer W, Ziller M, Wagner U, Hadji P. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009;20:431-436.